Skip to content
sellWeak10b5-1 plan

Katherine S Zanotti sold $171k of EXAS

director at EXACT SCIENCES CORP. 3,207 shares at an average of $53.20, traded Jun 13, 2025, filed Jun 16, 2025.

Warning score
6
Value
$171k
3,207 shares
Holdings after
72,759
-4% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $171k at market
    +11
  • Share of holdings sold
    Sold 4.2% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000950170-25-086885, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 12, 2025AGrant or award
Common Stock10b5-1
+5,398$0.00$075,966Jun 16, 2025
Jun 13, 2025SOpen-market sale
Common Stock10b5-1
-3,207$53.20$171k72,759Jun 16, 2025

Related signals

Other insiders at EXACT SCIENCES CORP and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
12Weak
EXASsell10b5-1
EXACT SCIENCES CORP
Brian Baranick
EVP, GM, Precision Oncology
$200k
2,858 shares
-11%
5Weak
EXASsell10b5-1
EXACT SCIENCES CORP
James Edward Doyle
director
$120k
2,000 shares
-3%
2Weak
EXASsell10b5-1
EXACT SCIENCES CORP
James Edward Doyle
director
$62k
1,485 shares
-2%
50Moderate
EXASbuy
EXACT SCIENCES CORP
Kevin T Conroy
President and CEO
$1.0M
19,500 shares
+2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Katherine S Zanotti sold $171k of EXAS | InsiderTell